NCT06157957Not yet recruiting
Cancer Screening Smoking Cessation AND Respiratory Assessment
Lung Cancer Screening Pilot Programme: Cancer Screening Smoking Cessation AND Respiratory Assessment
Source: ClinicalTrials.gov · Last updated 27 Dec 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The CASSANDRA project (Cancer Screening, Smoking Cessation, AND Respiratory Assessment) is a project led by SEPAR whose main coordinators are Dr. Luis Seijo, a pulmonologist at the Clínica Universitaria de Navarra, and Dr. Juan Carlos Trujillo-Reyes, a thoracic surgeon at the Hospital de la Santa Creu I Sant Pau and Coordinator of the Thoracic Oncology Area, in addition to the collaboration of a large number of professionals with expertise in lung cancer screening. Despite its proven efficacy, Spain does not yet have a unified lung cancer screening protocol. The aim of the CASSANDRA project is to initiate a national screening program that can join forces with existing smoking cessation programs in Spain, which have proven to be insufficient in reducing the number of people affected by lung cancer. CASSANDRA aims to analyze the feasibility of implementing a lung cancer screening program in Spain implemented in the public health system and carry out a cost-effectiveness analysis
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40000 (estimated)
- First submitted
- 24 Nov 2023
- Start date
- 31 Dec 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Diseases
- Lung cancer
- NCT number
- NCT06157957
What you commit to
- Study type: Interventional
- Planned participants: 40000
- From 31 Dec 2023 to the primary completion date, 31 Dec 2024
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Performing a chest CT for any reason in the previous year or planned CT for any reason in the next 3 months.
- Subjects with a history of any cancer (except non-melanoma skin cancer) in the 5 years prior to inclusion in the screening program.
Other illness
- Pre-existing or new-onset comorbidities that, in the opinion of the coordinator, prevent surgical resection if lung cancer is found on low dose computed tomography (LDCT) scan, for example, severe chronic obstructive pulmonary disease (COPD) with forced expiratory volume at one second (FEV1) \< 30%.
Other
- Inability to sign the informed consent or collaborate with the CT scan.
Who the study is looking for
- Age 50-75 years active smoker with cumulative dose of \>20 packets/year
- Age 50-75 years ex-smoker less than 15 years old with cumulative dose of \> 20 packets/year
Age in the registry: 50 years to 75 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.